三十年来接受机械通气的ICU患者死亡率及基础风险趋势:感染预防研究队列的组水平分析
该研究对1985至2021年发表的210项研究(169项来自系统评价)进行组水平荟萃回归分析,纳入147项随机同期对照试验和63项观察性研究,所有组均满足ICU患者中超过50%接受超过24小时机械通气且有死亡率数据。提取ICU死亡率(第21天或之前删失)或晚期(第21天后)死亡率、组平均年龄和组平均APACHE II评分,建立五个荟萃回归模型,分别对发表年份进行年龄、APACHE II评分、研究干预类型等组水平参数的调整。结果显示死亡率每十年增加小于1个百分点(p=0.43),组平均APACHE II评分每十年增加1.83分(95%CI 0.51-3.15),组平均年龄每十年增加3.9岁(95%CI 1.1-6.7);仅在对组平均年龄和组平均APACHE II评分均进行风险调整的模型中,死亡率才呈现显著下降。去污染研究的同期对照组死亡率 paradoxically 比基准高5个百分点且离散度更大,原因未明。
要点
- 1985至2021年210项研究中,机械通气ICU患者死亡率每十年增加小于1个百分点(p=0.43),未达统计学显著。
- 同期组平均APACHE II评分每十年增加1.83分(95%CI 0.51-3.15),组平均年龄每十年增加3.9岁(95%CI 1.1-6.7)。
- 仅在对组平均年龄和组平均APACHE II评分均调整的模型中,死亡率才呈现显著下降。
- 去污染研究的同期对照组死亡率比基准高5个百分点,且离散度更大,原因仍未解释。
适用人群与场景
- ICU患者中超过50%接受超过24小时机械通气且有死亡率数据的研究组。
- 纳入147项随机同期对照试验(VAP预防干预,主要来自13项Cochrane综述)和63项观察性研究(主要来自4项系统评价),共210项研究。
研究设计与关键结果
- 研究类型:组水平荟萃回归分析,纳入210项发表于1985至2021年的研究(169项来自系统评价),其中147项随机同期对照试验、63项观察性研究。
- 主要终点:死亡率每十年增加小于1个百分点(p=0.43);组平均APACHE II评分每十年增加1.83分(95%CI 0.51-3.15);组平均年龄每十年增加3.9岁(95%CI 1.1-6.7)。
- 仅在对组平均年龄和组平均APACHE II评分均调整的模型中,死亡率呈现显著下降。
- 去污染研究的同期对照组死亡率比基准高5个百分点,且离散度更大。
证据类型、等级与局限
- 证据类型:组水平荟萃回归分析(基于随机同期对照试验和观察性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Has either the underlying risk or the mortality incidence among ICU patients receiving mechanical ventilation (MV) in the literature changed in recent decades? Interpreting ICU mortality trends requires an adjusted analysis accounting for changes in underlying patient risk.
METHODS: Control and intervention groups from 147 randomized concurrent control trials (RCCT) of various VAP prevention interventions, as listed primarily within 13 Cochrane reviews and 63 observational studies listed primarily within four systematic reviews. Eligible studies were those including ICU patients with > 50% of patients receiving > 24 h of MV with mortality data available. ICU mortality (censored day 21 or before) or late (after day 21) mortality together with group-mean age, and group-mean APACHE II scores were extracted from all groups. These incidences were summarized in five meta-regression models versus publication year being variously adjusted for age, APACHE II scores, type of study intervention and other group level parameters.
RESULTS: Among 210 studies published between 1985 and 2021, 169 being found in systematic reviews, the increase per decade in mean mortality incidence, group-mean APACHE II scores, and group-mean age, were < 1 percentage point (p = 0.43), 1.83 (95% CI; 0.51-3.15) points, and 3.9 (95% CI; 1.1-6.7) years, respectively. Only in the model with risk adjustment for both group-mean age and group-mean APACHE II score was a significant decline in mortality apparent. In all models, the mortality incidence among concurrent control groups of decontamination studies was paradoxically five percentage points higher than benchmark and showed greater dispersion.
CONCLUSION: Mortality incidence has changed little over 35 years among ICU infection prevention studies whilst the patient age and underlying disease severity, measured as APACHE II, have both increased. The paradoxically high mortality among concurrent control groups within studies of decontamination methods of infection prevention remains unaccounted for.
参考来源
- Hurley JC. Trends in ICU mortality and underlying risk over three decades among mechanically ventilated patients. A group level analysis of cohorts from infection prevention studies. Ann Intensive Care. 2023. PMID: 37432605. doi:10.1186/s13613-023-01159-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。